or Try an Advanced Search...

    Technical Analysis for ANRO - Alto Neuroscience, Inc.

    Grade Last Price % Change Price Change
    B 16.10 3.80% 0.59
    ANRO closed up 3.8 percent on Wednesday, May 1, 2024, on 69 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A Up Up
    Historical ANRO trend table...
    Date Alert Name Type % Chg
    MACD Bullish Centerline Cross Bullish 0.00%
    Stochastic Reached Overbought Strength 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Outside Day Range Expansion 0.00%
    Above Upper BB Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Inside Day Range Contraction 3.80%
    Above Upper BB Strength 3.80%
    Upper Bollinger Band Touch Strength 3.80%
    Older End-of-Day Signals for ANRO ...

       Recent Intraday Alerts

    Alert Time
    Up 5% about 19 hours ago
    Up 1 ATR about 19 hours ago
    60 Minute Opening Range Breakout about 19 hours ago
    Rose Above Previous Day's High about 19 hours ago
    Outside Day about 19 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ANRO Chart by TradingView
    Basic chart:

    Profile

    Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Alto's Precision Psychiatry Platform™ measures brain biomarkers by analyzing EEG activity, neurocognitive assessments, wearable data, and other factors to better identify which patients are more likely to respond to Alto product candidates. Alto’s clinical-stage pipeline includes novel drug candidates in depression, PTSD, schizophrenia, and other mental health conditions.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Neuroscience Schizophrenia Biomarkers Depression Neurophysiology Post Traumatic Stress Disorder Electroencephalography Neurocognition Ptsd

    Is ANRO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 23 Alto Neuroscience schizophrenia treatment shows good phase 1 results
    Apr 23 Alto Neuroscience Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia
    Apr 9 Alto Neuroscience (ANRO): Strong Industry, Solid Earnings Estimate Revisions
    Apr 3 Alto Neuroscience Announces Initiation of Phase 2 Study of ALTO-203 in Patients with Major Depressive Disorder
    Mar 21 Alto Neuroscience GAAP EPS of -$9.73
    Mar 21 Alto Neuroscience Reports Full Year 2023 Financial Results and Recent Business Highlights
    Mar 21 Alto Neuroscience: Potential First-In-Class Approach To Targeting CNS Disorders
    Mar 11 Alto Neuroscience Appoints Maha Radhakrishnan, M.D., to Board of Directors
    Mar 7 Alto Neuroscience to Participate in Upcoming Investor Conferences
    Feb 27 Stifel, Baird, Jefferies bullish on Alto Neuroscience, cite upcoming data
    See more ANRO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 24.0
    52 Week Low 12.7798
    Average Volume 187,664
    200-Day Moving Average 0.00
    50-Day Moving Average 14.66
    20-Day Moving Average 14.24
    10-Day Moving Average 14.37
    Average True Range 1.04
    RSI (14) 61.54
    ADX 16.89
    +DI 27.38
    -DI 11.65
    Chandelier Exit (Long, 3 ATRs) 13.43
    Chandelier Exit (Short, 3 ATRs) 15.89
    Upper Bollinger Bands 15.72
    Lower Bollinger Band 12.76
    Percent B (%b) 1.13
    BandWidth 20.77
    MACD Line 0.07
    MACD Signal Line -0.23
    MACD Histogram 0.3015
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 18.48
    Resistance 3 (R3) 18.36 17.45 18.08
    Resistance 2 (R2) 17.45 16.84 17.51 17.95
    Resistance 1 (R1) 16.77 16.47 17.11 16.89 17.82
    Pivot Point 15.86 15.86 16.03 15.92 15.86
    Support 1 (S1) 15.19 15.26 15.53 15.31 14.38
    Support 2 (S2) 14.28 14.88 14.34 14.25
    Support 3 (S3) 13.60 14.28 14.12
    Support 4 (S4) 13.72